Raimon Sanmarti Sala

Title: Raimon Sanmarti Sala: Innovator in Rheumatoid Arthritis Detection

Introduction

Raimon Sanmarti Sala is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biomedical research, particularly in the detection of rheumatoid arthritis. His innovative work has led to the development of a unique chimeric polypeptide that plays a crucial role in diagnosing this autoimmune disease.

Latest Patents

Raimon Sanmarti Sala holds a patent for a "Citrullinated fibrin-filaggrin chimeric polypeptide capable of detecting the antibodies generated in rheumatoid arthritis." This invention involves a chimeric polypeptide that includes at least two citrullinated peptide subunits: one derived from the α or β chain of fibrin and another from filaggrin. The invention also encompasses an antigenic composition, a method, and a kit for diagnosing rheumatoid arthritis by detecting the autoantibodies produced during the disease.

Career Highlights

Throughout his career, Raimon has worked with esteemed organizations such as the Consejo Superior de Investigaciones Científicas and the Fundació Clínic per a la Recerca Biomèdica. His work in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Raimon has collaborated with notable colleagues, including Isabel Haro Villar and José M Gomora Elena. These partnerships have enriched his research and fostered innovation in the field of rheumatoid arthritis detection.

Conclusion

Raimon Sanmarti Sala's contributions to the detection of rheumatoid arthritis through his innovative chimeric polypeptide highlight his role as a significant inventor in the biomedical field. His work continues to impact the diagnosis and understanding of autoimmune diseases.